US Patent 7345054 Heterocyclic inhibitors of ERK2 and uses thereof
Patent 7345054 was granted and assigned to Vertex Pharmaceuticals on March, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 15 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+110 characters)
Article
Patent abstract
Described herein are compounds that are useful as protein kinase inhibitors having the formula:
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07345054 Heterocyclic inhibitors of ERK2 and uses thereof US Patent 7345054 Heterocyclic inhibitors of ERK2 and uses thereof
Infobox
Patent Number
0734505400
Patent Number
734505400
Edits on 24 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073450540
Date of Patent
March 18, 2008
0Patent Application Number
110771880
Date Filed
March 10, 2005
0Official Website
Patent Primary Examiner
Edits on 28 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073450540
Date of Patent
March 18, 2008
0Patent Application Number
110771880
Date Filed
March 10, 2005
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 24 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07345054 Heterocyclic inhibitors of ERK2 and uses thereof
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07345054
Date of patent
March 18, 2008
Patent application number
11077188
Date Filed
March 10, 2005
Patent primary examiner
Find more entities like US Patent 7345054 Heterocyclic inhibitors of ERK2 and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
